Last year, an investigator submits an application for a NIH R21 grant (Parent R21). The application is assigned to and reviewed by NICHD. The grant is not funded. Now the investigator wishes to resubmit but NICHD is no longer an Parent R21 sponsor. There
is a plausible scientific argument for assignment to a different institute.
Given that applications are submitted to NIH and not to individual institutes, is there is any question that the next submission qualifies as a resubmission? Isn’t the real question here a grantsmanship one?
Thoughts?
Charlie Hathaway
*************************************
Charles B. Hathaway, Ph.D.
Assistant Dean for Research Administration
Director, Office of Research Administration
School of Medicine
New York Medical College
40 Sunshine Cottage Road, GN-B28
Valhalla, NY 10595-1524
914.594.2600